Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001739104-25-000032
Filing Date
2025-03-27
Accepted
2025-03-27 12:30:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A noticefinal.htm DEFA14A 4501
2 GRAPHIC noticefinal001.jpg GRAPHIC 89904
3 GRAPHIC noticefinal002.jpg GRAPHIC 160356
4 GRAPHIC noticefinal003.jpg GRAPHIC 104423
  Complete submission text file 0001739104-25-000032.txt   494150
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38661 | Film No.: 25777967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)